Ghulam Mustafa

Dr. Ghulam Mustafa


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2020 in Processes
Verified
Journal Article
Open access
PDF file
Outi Salo-AhenOuti Salo-Ahen
Outi Salo-Ahen
IAIda Alanko
Ida Alanko
Rajendra BhadaneRajendra Bhadane
Rajendra Bhadane
ABAlexandre M.J.J. Bonvin
Alexandre M.J.J. Bonvin
RHRodrigo Vargas Honorato
Rodrigo Vargas Honorato
MVMichiel Vanmeert
Michiel Vanmeert
Molecular dynamics (MD) simulations have become increasingly useful in the modern drug development process. In this review, we give a broad overview of the current application possibilities of MD in drug discovery and pharmaceutical development. Starting from the target validation step of the drug development process, we give several examples of how MD studies can give important insights into the dynamics and function of identified drug targets such as sirtuins, RAS proteins, or intrinsically disordered proteins. The role of MD in antibody design is also reviewed. In the lead discovery and lead optimization phases, MD facilitates the evaluation of the binding energetics and kinetics of the ligand-receptor interactions, therefore guiding the choice of the best candidate molecules for further development. The importance of considering the biological lipid bilayer environment in the MD simulations of membrane proteins is also discussed, using G-protein coupled receptors and ion channels as well as the drug-metabolizing cytochrome P450 enzymes as relevant examples. Lastly, we discuss the emerging role of MD simulations in facilitating the pharmaceutical formulation development of drugs and candidate drugs. Specifically, we look at how MD can be used in studying the crystalline and amorphous solids, the stability of amorphous drug or drug-polymer formulations, and drug solubility. Moreover, since nanoparticle drug formulations are of great interest in the field of drug delivery research, different applications of nano-particle simulations are also briefly summarized using multiple recent studies as examples. In the future, the role of MD simulations in facilitating the drug development process is likely to grow substantially with the increasing computer power and advancements in the development of force fields and enhanced MD methodologies.

25 May 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
RMRajagopal Murugan
Rajagopal Murugan
SSStephen W. Scally
Stephen W. Scally
GCGiulia Costa
Giulia Costa
GMGhulam Mustafa
Ghulam Mustafa
ETElaine Thai
Elaine Thai
HWHedda Wardemann
Hedda Wardemann

8 August 2024 in Journal of the American Chemical Society
Verified
Journal Article
Open access
AKAndreas Sebastian Klein
Andreas Sebastian Klein
FLFlorian Leiss-Maier
Florian Leiss-Maier
RMRahel Mühlhofer
Rahel Mühlhofer
BBBenedikt Boesen
Benedikt Boesen
GMGhulam Mustafa
Ghulam Mustafa
CZCathleen Zeymer
Cathleen Zeymer
Cerium photoredox catalysis has emerged as a powerful strategy to activate molecules under mild conditions. Radical intermediates are formed using visible light and simple complexes of the earth-abundant lanthanide. Here, we report an artificial photoenzyme enabling this chemistry inside a protein. We utilize a de novo designed protein scaffold that tightly binds lanthanide ions in its central cavity. Upon visible-light irradiation, the cerium-dependent enzyme catalyzes the radical C-C bond cleavage of 1,2-diols in aqueous solution. Protein engineering led to variants with improved photostability and metal binding behavior. The photoenzyme cleaves a range of aromatic and aliphatic substrates, including lignin surrogates. Surface display of the protein scaffold on Escherichia coli facilitates whole-cell photobiocatalysis. Furthermore, we show that also natural lanthanide-binding proteins are suitable for this approach. Our study thus demonstrates a new-to-nature enzymatic photoredox activity with broad catalytic potential.

1 February 2016 in Bioorganic Chemistry
Verified
Journal Article
Closed access
WVWolfgang Voelter
Wolfgang Voelter
MMM. Ahmad Mesaik
M. Ahmad Mesaik
OAOmer M. Abdalla
Omer M. Abdalla
FRFazal Rahim
Fazal Rahim
SSSamreen Soomro
Samreen Soomro
WVWolfgang Voelter
Wolfgang Voelter

1 February 2019 in Biophysical Journal
Verified
Journal Article
Open access
GMGhulam Mustafa
Ghulam Mustafa
PNPrajwal P. Nandekar
Prajwal P. Nandekar
TCTyler J. Camp
Tyler J. Camp
NBNeil J. Bruce
Neil J. Bruce
MGMichael C. Gregory
Michael C. Gregory
Rebecca WadeRebecca Wade
Rebecca Wade
Human cytochrome P450 (CYP) enzymes play an important role in the metabolism of drugs, steroids, fatty acids, and xenobiotics. Microsomal CYPs are anchored in the endoplasmic reticulum membrane by an N-terminal transmembrane (TM) helix that is connected to the globular catalytic domain by a flexible linker sequence. However, the structural and functional importance of the TM-helix is unclear because it has been shown that CYPs can still associate with the membrane and have enzymatic activity in reconstituted systems after truncation or modification of the N-terminal sequence. Here, we investigated the effect of mutations in the N-terminal TM-helix residues of two human steroidogenic enzymes, CYP 17A1 and CYP 19A1, that are major drug targets for cancer therapy. These mutations were originally introduced to increase the expression of the proteins in Escherichia coli. To investigate the effect of the mutations on protein-membrane interactions and function, we carried out coarse-grained and all-atom molecular dynamics simulations of the CYPs in a phospholipid bilayer. We confirmed the orientations of the globular domain in the membrane observed in the simulations by linear dichroism measurements in a Nanodisc. Whereas the behavior of CYP 19A1 was rather insensitive to truncation of the TM-helix, mutations in the TM-helix of CYP 17A1, especially W2A and E3L, led to a gradual drifting of the TM-helix out of the hydrophobic core of the membrane. This instability of the TM-helix could affect interactions with the allosteric redox partner, cytochrome b5, required for CYP 17A1's lyase activity. Furthermore, the simulations showed that the mutant TM-helix influenced the membrane interactions of the CYP 17A1 globular domain. In some simulations, the mutated TM-helix obstructed the substrate access tunnel from the membrane to the CYP active site, indicating a possible effect on enzyme function.

20 January 2015 in Journal of Molecular Recognition
Verified
Journal Article
Closed access
PDF file
XYXiaofeng Yu
Xiaofeng Yu
VCVlad Cojocaru
Vlad Cojocaru
GMGhulam Mustafa
Ghulam Mustafa
Outi Salo-AhenOuti Salo-Ahen
Outi Salo-Ahen
GLGalina I. Lepesheva
Galina I. Lepesheva
Rebecca WadeRebecca Wade
Rebecca Wade